MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 357 filers reported holding MEDIVATION INC in Q3 2015. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $3,388,000 | +97.4% | 56,182 | +50.5% | 0.10% | +96.2% |
| Q1 2016 | $1,716,000 | +31.1% | 37,330 | +21.2% | 0.05% | +26.8% |
| Q3 2015 | $1,309,000 | -16.7% | 30,807 | +123.8% | 0.04% | -12.8% |
| Q2 2015 | $1,572,000 | -47.5% | 13,764 | -40.7% | 0.05% | -44.0% |
| Q1 2015 | $2,996,000 | +17.1% | 23,214 | -9.6% | 0.08% | +13.5% |
| Q4 2014 | $2,558,000 | +49.7% | 25,680 | +48.6% | 0.07% | +45.1% |
| Q3 2014 | $1,709,000 | -27.1% | 17,286 | -55.8% | 0.05% | -37.8% |
| Q3 2013 | $2,345,000 | -21.2% | 39,122 | -35.3% | 0.08% | -21.9% |
| Q2 2013 | $2,975,000 | – | 60,475 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $158,535,000 | 79.84% |
| Cormorant Asset Management, LP | 546,900 | $34,903,000 | 10.13% |
| BB BIOTECH AG | 1,479,706 | $94,435,000 | 5.04% |
| PFM Health Sciences, LP | 2,719,859 | $173,581,000 | 3.49% |
| Partner Investment Management, L.P. | 219,981 | $14,039,000 | 3.19% |
| Orbimed Advisors | 3,123,500 | $199,342,000 | 2.93% |
| Antipodean Advisors LLC | 525,000 | $33,506,000 | 2.90% |
| Eventide Asset Management | 134,800 | $8,603,000 | 2.65% |
| Bain Capital Public Equity Management, LLC | 1,428,117 | $91,142,000 | 2.58% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 257,055 | $16,405,000 | 2.52% |